HAVCR2 and cancer: Recent studies have shown that TIM-3 expressed on T cells and cancer stem cells also suppresses immune responses through inducing the development of myeloid-derived suppressor cells (MDSCs) that are a heterogeneous CD11b+Gr-1+ myeloid cell population.